These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37533168)

  • 1. Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol.
    Kojić D; Radunović A; Bukumirić Z; Rajsic S; Sušić M; Marić M; Žugić V; Jurčević R; Tomović M
    Clin Cardiol; 2023 Oct; 46(10):1220-1226. PubMed ID: 37533168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are antiarrhythmic agents indicated in premature ventricular complex-induced cardiomyopathy and when?
    Kantharia BK; Shah AN
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):574-582. PubMed ID: 37676022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
    Hyman MC; Mustin D; Supple G; Schaller RD; Santangeli P; Arkles J; Lin D; Muser D; Dixit S; Nazarian S; Epstein AE; Callans DJ; Marchlinski FE; Frankel DS
    Heart Rhythm; 2018 Feb; 15(2):159-163. PubMed ID: 29405947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study.
    Bertels RA; Kammeraad JAE; Zeelenberg AM; Filippini LH; Knobbe I; Kuipers IM; Blom NA
    Pediatr Cardiol; 2021 Apr; 42(4):883-890. PubMed ID: 33515328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of medical therapy for treatment of idiopathic frequent premature ventricular complexes.
    Tang JKK; Andrade JG; Hawkins NM; Laksman ZW; Krahn AD; Bennett MT; Heilbron B; Chakrabarti S; Yeung-Lai-Wah JA; Deyell MW
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2246-2253. PubMed ID: 34216056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators.
    Raad M; Yogasundaram H; Oranefo J; Guandalini G; Markman T; Hyman M; Schaller R; Supple G; Deo R; Nazarian S; Riley M; Lin D; Garcia F; Dixit S; Epstein AE; Callans D; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2024 May; 10(5):846-853. PubMed ID: 38551548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
    Stec S; Sikorska A; Zaborska B; Kryński T; Szymot J; Kułakowski P
    Kardiol Pol; 2012; 70(4):351-8. PubMed ID: 22528707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of Benign Ventricular Premature Beats or Ventricular Tachycardia with Catheter Ablation versus Two Different Optimal Antiarrhythmic Drug Treatment Regimens (Sotalol or Verapamil/Flecainide).
    Haanschoten DM; Vernooy K; Beukema RJ; Szili-Torok T; Ter Bekke RMA; Khan M; de Jong JSSG; Otten AM; Adiyaman A; Smit JJJ; Delnoy PPHM; Ramdat Misier AR; Elvan A
    Cardiology; 2020; 145(12):795-801. PubMed ID: 32841937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of propafenone on premature ventricular contractions (PVC): an analysis based on heart rate dependency of PVCs.
    Saikawa T; Niwa H; Ito M; Ishida S; Nakagawa M; Maeda T; Takeshita Y; Takakura T; Sakata T
    Jpn Heart J; 2001 Nov; 42(6):701-11. PubMed ID: 11933920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
    Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
    Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
    Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
    Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study.
    Zhong L; Lee YH; Huang XM; Asirvatham SJ; Shen WK; Friedman PA; Hodge DO; Slusser JP; Song ZY; Packer DL; Cha YM
    Heart Rhythm; 2014 Feb; 11(2):187-93. PubMed ID: 24157533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
    Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.